Reported 5 months ago
The article discusses two biotech stocks worth investing in, Vertex Pharmaceuticals (NASDAQ: VRTX) and Regeneron Pharmaceuticals (NASDAQ: REGN). Vertex is highlighted for its focus on cystic fibrosis treatments and upcoming gene-editing therapies, while Regeneron's growth drivers include cancer medicine Libtayo and Dupixent for eczema, with potential peak sales reaching $20 billion. Both companies have promising pipelines and growth opportunities, making them attractive investment options in the biotech industry.
Source: YAHOO